What's new

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 24, Status: Authorised

Apr 14, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Junkyard Find: 1992 Dodge Colt Hatchback

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Tenkasi (previously O...

Related Posts

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0

EMEA-002022-PIP02-23

EMEA-002022-PIP02-23

Feb 13, 2025  0

Submission deadlines for orphan designations

Submission deadlines for orphan designations

Feb 9, 2025  0